{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:55:04Z","timestamp":1793998504427,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04749-x","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T03:11:08Z","timestamp":1744945868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingnan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"4749_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","volume":"21","author":"M Galli","year":"2024","unstructured":"Galli M, Niccoli G, De Maria G, Brugaletta S, Montone RA, Vergallo R, Benenati S, Magnani G, D\u2019Amario D, Porto I, Burzotta F, Abbate A, Angiolillo DJ, Crea F. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat Rev Cardiol. 2024;21:283\u201398.","journal-title":"Nat Rev Cardiol"},{"key":"4749_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barrere-Lemaire","year":"2024","unstructured":"Barrere-Lemaire S, Vincent A, Jorgensen C, Piot C, Nargeot J, Djouad F. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing. Physiol Rev. 2024;104:659\u2013725.","journal-title":"Physiol Rev"},{"key":"4749_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41569-023-00913-y","volume":"21","author":"E Avolio","year":"2024","unstructured":"Avolio E, Campagnolo P, Katare R, Madeddu P. The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction. Nat Rev Cardiol. 2024;21:106\u201318.","journal-title":"Nat Rev Cardiol"},{"key":"4749_CR4","doi-asserted-by":"crossref","unstructured":"Chang Y, Li S, Chen K, Wang Y, Huang D, Wang X, Li J. Mitochondrial ferritin Inhibition aggravates pacing-induced ventricular arrhythmias after myocardial infarction by promoting cardiomyocyte ferroptosis. Cell Signal 2025: 111683.","DOI":"10.1016\/j.cellsig.2025.111683"},{"key":"4749_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10020-025-01102-y","volume":"31","author":"C Wu","year":"2025","unstructured":"Wu C, Shen X, Lou P, Song D. Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting Endoplasmic reticulum stress. Mol Med. 2025;31:32.","journal-title":"Mol Med"},{"key":"4749_CR6","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","volume":"36","author":"T Munzel","year":"2015","unstructured":"Munzel T, Gori T, Keaney JJ, Maack C, Daiber A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J. 2015;36:2555\u201364.","journal-title":"Eur Heart J"},{"key":"4749_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park TJ, Park JH, Lee GS, Lee JY, Shin JH, Kim MW, Kim YS, Kim JY, Oh KJ, Han BS, Kim WK, Ahn Y, Moon JH, Song J, Bae KH, Kim DH, Lee EW, Lee SC. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 2019;10:835.","journal-title":"Cell Death Dis"},{"key":"4749_CR8","doi-asserted-by":"crossref","unstructured":"Li H, Ding J, Liu W, Wang X, Feng Y, Guan H, Chen Z. Plasma exosomes from patients with acute myocardial infarction alleviate myocardial injury by inhibiting ferroptosis through miR-26b-5p\/SLC7A11 axis. Life sciences (1973). 2023;322:121649.","DOI":"10.1016\/j.lfs.2023.121649"},{"key":"4749_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"4749_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","volume":"83","author":"E Sendinc","year":"2023","unstructured":"Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83:428\u201341.","journal-title":"Mol Cell"},{"key":"4749_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13578-024-01286-6","volume":"14","author":"Z Gao","year":"2024","unstructured":"Gao Z, Zha X, Li M, Xia X, Wang S. Insights into the m(6)A demethylases FTO and ALKBH5: structural, biological function, and inhibitor development. Cell Biosci. 2024;14:108.","journal-title":"Cell Biosci"},{"key":"4749_CR12","doi-asserted-by":"crossref","unstructured":"Rong H, Wang D, Wang Y, Dong C, Wang G. YTHDF1 in tumor cell metabolism: an updated review. Molecules 2023; 29.","DOI":"10.3390\/molecules29010140"},{"key":"4749_CR13","doi-asserted-by":"crossref","unstructured":"Wang H, Han J, Kong H, Ma C, Zhang XA. The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases. Biomolecules. 2025;15.","DOI":"10.3390\/biom15020247"},{"key":"4749_CR14","doi-asserted-by":"crossref","unstructured":"Yang K, Zhao Y, Hu J, Gao R, Shi J, Wei X, Chen J, Hu K, Sun A, Ge J. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. J Adv Res 2023.","DOI":"10.2139\/ssrn.4376158"},{"key":"4749_CR15","doi-asserted-by":"crossref","unstructured":"Yu H, Li QS, Guo JN, Zhang Z, Lang XZ, Liu YN, Qin L, Su X, Zhang QW, Xue YD, Gong LL, Xu N, Li M, Zhao WS, Zhao XM, Zhang WY, Yao YJ, Chen XM, Zhang Z, Li W, Wang HX, Cai BZ, Li JM, Wang N. METTL14-mediated m(6)A methylation of pri-miR-5099 to facilitate cardiomyocyte pyroptosis in myocardial infarction. Acta Pharmacol Sin 2025.","DOI":"10.1038\/s41401-025-01485-y"},{"key":"4749_CR16","doi-asserted-by":"publisher","first-page":"1078205","DOI":"10.3389\/fphar.2023.1078205","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X, Li H, Jiang T. Dapagliflozin alleviates myocardial ischemia\/reperfusion injury by reducing ferroptosis via MAPK signaling Inhibition. Front Pharmacol. 2023;14:1078205.","journal-title":"Front Pharmacol"},{"key":"4749_CR17","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388\u201399.","journal-title":"Cell"},{"key":"4749_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"4749_CR19","doi-asserted-by":"publisher","first-page":"122113","DOI":"10.1016\/j.lfs.2023.122113","volume":"332","author":"NK Kawasaki","year":"2023","unstructured":"Kawasaki NK, Suhara T, Komai K, Shimada BK, Yorichika N, Kobayashi M, Baba Y, Higa JK, Matsui T. The role of ferroptosis in cell-to-cell propagation of cell death initiated from focal injury in cardiomyocytes. Life Sci. 2023;332:122113.","journal-title":"Life Sci"},{"key":"4749_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41418-022-01110-z","volume":"30","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Qiao Y, He D, Tian A, Li Z. Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction. Cell Death Differ. 2023;30:825\u201338.","journal-title":"Cell Death Differ"},{"key":"4749_CR21","doi-asserted-by":"publisher","first-page":"115195","DOI":"10.1016\/j.biopha.2023.115195","volume":"165","author":"T Yang","year":"2023","unstructured":"Yang T, Yang Q, Lai Q, Zhao J, Nie L, Liu S, Yang J, Chu C. AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1\/parkin pathway to improve myocardial fibrosis with myocardial infarction. Biomed Pharmacother. 2023;165:115195.","journal-title":"Biomed Pharmacother"},{"key":"4749_CR22","doi-asserted-by":"publisher","first-page":"113572","DOI":"10.1016\/j.biopha.2022.113572","volume":"154","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yao M, Jiang L, Wang L, Yang Y, Wang Q, Qian X, Zhao Y, Qian J. Dexmedetomidine attenuates myocardial ischemia\/reperfusion-induced ferroptosis via AMPK\/GSK-3beta\/Nrf2 axis. Biomed Pharmacother. 2022;154:113572.","journal-title":"Biomed Pharmacother"},{"key":"4749_CR23","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu Q, Zhang N, Gan X, Chen L, Wang R, Liang R, Jian J. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine (Stuttgart). 2023;119:154999.","journal-title":"Phytomedicine (Stuttgart)"},{"key":"4749_CR24","doi-asserted-by":"publisher","first-page":"175569","DOI":"10.1016\/j.ejphar.2023.175569","volume":"943","author":"D Li","year":"2023","unstructured":"Li D, Zhang G, Wang Z, Guo J, Liu Y, Lu Y, Qin Z, Xu Y, Cao C, Wang B, Guo Q, Wang Y, Liu G, Cui X, Zhang J, Tang J. Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. Eur J Pharmacol. 2023;943:175569.","journal-title":"Eur J Pharmacol"},{"key":"4749_CR25","doi-asserted-by":"publisher","first-page":"789923","DOI":"10.3389\/fmolb.2021.789923","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Hua W, Dang Y, Cheng Y, Wang J, Zhang X, Teng M, Wang S, Zhang M, Kong Z, Lu X, Zheng Y. Validated impacts of N6-Methyladenosine methylated mRNAs on apoptosis and angiogenesis in myocardial infarction based on MeRIP-Seq analysis. Front Mol Biosci. 2022;8:789923.","journal-title":"Front Mol Biosci"},{"key":"4749_CR26","doi-asserted-by":"publisher","first-page":"46583","DOI":"10.1021\/acsami.3c06318","volume":"15","author":"B Huang","year":"2023","unstructured":"Huang B, Xie L, Ke M, Fan Y, Tan J, Ran J, Zhu C. Programmed release METTL3-14 inhibitor microneedle protects myocardial function by reducing Drp1 m6A Modification-Mediated mitochondrial fission. Acs Appl Mater Interfaces. 2023;15:46583\u201397.","journal-title":"Acs Appl Mater Interfaces"},{"key":"4749_CR27","doi-asserted-by":"publisher","first-page":"103157","DOI":"10.1016\/j.redox.2024.103157","volume":"72","author":"L Wu","year":"2024","unstructured":"Wu L, Du Y, Wang L, Zhang Y, Ren J. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis. Redox Biol. 2024;72:103157.","journal-title":"Redox Biol"},{"key":"4749_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, Liu L, Liu G, Sun H, Sun M, Wang J, Li Z, Fan J, Zhang Q, Li C, Situ F, Xue J, Jia Z, Zhang C, Zhang S, Shan C. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"4749_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10863-024-10006-1","volume":"56","author":"Z Tang","year":"2024","unstructured":"Tang Z, Huang X, Mei H, Zheng Z. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner. J Bioenerg Biomembr. 2024;56:149\u201357.","journal-title":"J Bioenerg Biomembr"},{"key":"4749_CR30","doi-asserted-by":"crossref","unstructured":"Fang M, Li T, Wu Z. WTAP-mediated m6A modification of KLF6 aggravates hypoxia\/reoxygenation-induced human cardiomyocyte injury. Shock; 2024.","DOI":"10.1097\/SHK.0000000000002373"},{"key":"4749_CR31","doi-asserted-by":"crossref","unstructured":"Di Sanzo M, Quaresima B, Biamonte F, Palmieri C, Faniello MC. FTH1 pseudogenes in cancer and cell metabolism. Cells 2020; 9.","DOI":"10.3390\/cells9122554"},{"key":"4749_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2024.12.012","volume":"227","author":"B Zhu","year":"2025","unstructured":"Zhu B, Yang C, Hua S, Li K, Shang P, Chen X, Hua ZC. Lithium enhances ferroptosis sensitivity in melanoma cells and promotes CD8(+) T cell infiltration and differentiation. Free Radic Biol Med. 2025;227:233\u201345.","journal-title":"Free Radic Biol Med"},{"key":"4749_CR33","doi-asserted-by":"publisher","first-page":"114262","DOI":"10.1016\/j.intimp.2025.114262","volume":"150","author":"M Yang","year":"2025","unstructured":"Yang M, Lin D, He L, Shi X, Wang Y, Jin Y, Huang S. Cinnamaldehyde mitigates acute myocardial infarction by regulating ferroptosis through the PI3K-AKT signaling pathway. Int Immunopharmacol. 2025;150:114262.","journal-title":"Int Immunopharmacol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T03:11:22Z","timestamp":1744945882000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4749"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04749-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of MDKN Biotechnology Co., Lt (Approval No. MDKN-2024-048). All animal experiments should comply with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"295"}}